Nov 27, 2024 · Gleevec is a targeted therapy cancer treatment used to treat specific types of leukemia (blood cancer), bone marrow disorders, skin cancers and certain tumors of the stomach and …

Imatinib, sold under the brand names Gleevec and Glivec (both marketed worldwide by Novartis) among others, is an oral targeted therapy medication used to treat cancer. [2]

Visit resources tailored for our patient communities and their caregivers, including information around patient assistance, disease information and related resources.

COMMON BRAND NAME (S): Gleevec What should I tell my care team before I take this medication? They need to know if you have any of these conditions: Bleeding disorder Infection, especially a viral …

An open-label, multicenter, randomized trial (Gleevec versus nilotinib) was conducted to determine the efficacy of Gleevec versus nilotinib in adult patients with cytogenetically confirmed, newly diagnosed …

Feb 13, 2025 · Find patient medical information for Imatinib (Gleevec, Imkeldi) on WebMD including its uses, side effects and safety, interactions, pictures, warnings, and user ratings

Mar 24, 2022 · Imatinib (Gleevec) is an oral medication used to treat different types of cancer and blood conditions in adults. It can also be used in children with certain leukemias. This medication can …

The recommended dose of Gleevec is 400 mg/day for adult patients with ASM without the D816V c-Kit mutation. If c-Kit mutational status is not known or unavailable, treatment with Gleevec 400 mg/day …

Apr 11, 2018 · NCI-supported research led to a series of discoveries that resulted in the development of imatinib (Gleevec), a landmark drug that has vastly improved the outcomes of patients with a type of …

Dec 23, 2025 · Gleevec is used to treat newly diagnosed and relapsed Ph+ CML and ALL in adults/children, plus MDS/MPD, ASM, HES/CEL, DFSP, and Kit+ GIST. It is a brand name for imatinib.